A detailed history of Tempus Wealth Planning, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 2,288 shares of LLY stock, worth $2.07 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
2,288
Previous 2,231 2.55%
Holding current value
$2.07 Million
Previous $1.3 Million 36.85%
% of portfolio
0.87%
Previous 0.58%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $33,755 - $45,159
57 Added 2.55%
2,288 $1.78 Million
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $3,676 - $4,333
7 Added 0.31%
2,231 $1.3 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $6,520 - $8,989
15 Added 0.68%
2,224 $1.19 Million
Q2 2023

Jul 21, 2023

BUY
$350.74 - $468.98 $8,768 - $11,724
25 Added 1.14%
2,209 $1.04 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $2,485 - $2,918
-8 Reduced 0.36%
2,184 $750,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $2,371 - $2,702
-8 Reduced 0.36%
2,192 $709,000
Q1 2022

May 06, 2022

SELL
$234.69 - $291.66 $2,816 - $3,499
-12 Reduced 0.54%
2,200 $630,000
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $29,251 - $35,997
132 Added 6.35%
2,212 $511,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $1,462 - $1,691
-10 Reduced 0.48%
2,080 $308,000
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $2,381 - $2,947
-20 Reduced 0.95%
2,090 $290,000
Q4 2019

Mar 16, 2020

BUY
$106.92 - $132.43 $225,601 - $279,427
2,110 New
2,110 $277,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tempus Wealth Planning, LLC Portfolio

Follow Tempus Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tempus Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tempus Wealth Planning, LLC with notifications on news.